| Literature DB >> 35050124 |
Murat Akkurt Arslan1, Ioannis Kolman1, Cédric Pionneau2, Solenne Chardonnet2, Romain Magny1, Christophe Baudouin1,3,4,5, Françoise Brignole-Baudouin1,3,6,7, Karima Kessal1,3,4.
Abstract
This study aimed to investigate the human proteome profile of samples collected from whole (W) Schirmer strips (ScS) and their two parts-the bulb (B) and the rest of the strip (R)-with a comprehensive proteomic approach using a trapped ion mobility mass spectrometer, the timsTOF Pro. Eight ScS were collected from two healthy subjects at four different visits to be separated into three batches, i.e., 4W, 4B, and 4R. In total, 1582 proteins were identified in the W, B, and R batches. Among all identified proteins, binding proteins (43.4%) and those with catalytic activity (42.2%) constituted more than 80% of the molecular functions. The most represented biological processes were cellular processes (31.2%), metabolic processes (20.8%), and biological regulation (13.1%). Enzymes were the most represented protein class (41%), consisting mainly of hydrolases (47.5%), oxidoreductases (22.1%), and transferases (16.7%). The bulb (B), which is in contact with the conjunctiva, might collect both tear and cell proteins and therefore promote the identification of more proteins. Processing B and R separately before mass spectrometry (MS) analysis, combined with the high data acquisition speed and the addition of ion-mobility-based separation in the timsTOF Pro, can bring a new dimension to biomarker investigations of a limited sample such as tear fluid.Entities:
Keywords: Schirmer strip; proteome; signaling pathways; tears; timsTOF Pro
Year: 2021 PMID: 35050124 PMCID: PMC8778087 DOI: 10.3390/metabo12010002
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Overview of proteomics studies that have created the largest datasets for the healthy human tear proteome using LC-MS/MS from 2006 to 2020. NIPs, number of identified proteins; HSs, healthy subjects; MS, mass spectrometry; FDR, false discovery rate.
| Group, Year | Goal | Tear Sampling Method | Sample Preparation | MS Technology | Protein Identification | NIPs in HSs |
|---|---|---|---|---|---|---|
| de Souza et al., Genome Biol., 2006 [ | Characterization of the protein content of the human tear fluid from a HSs | Microcapillary method | With pre-fractionation of proteins with one-dimensional SDS-PAGE (13 fractions) or without (in-solution digestion of the whole samples) | Hybrid linear ion trap–Fourier-transform (LTQ-FT) | Two peptides with Mascot scores of >35, | 491 |
| Zhou et al., J. Proteomics, 2012 [ | Analysis of the human tear proteome from HSs | Schirmer strips | Offline SCX fractionation of peptides (6 fractions) | TripleTOF 5600 system | FDR <1% for peptides | 1543 |
| Aass et al., Anal. Biochem., 2015 [ | Optimizing extraction method from Schirmer strips to study the tear proteome | Schirmer strips | Offline SCX fractionation of peptides (16 fractions) | LTQ-Orbitrap XL hybrid | Peptide and protein with FDRs of <1% (high) and 5% (relaxed) | 1526 |
| Kandhavelu et al., J. Proteomics, 2016 [ | Comparison of tear proteins in control and fungal keratitis patients | Capillary method | N-linked glycoprotein enrichment or one-dimensional SDS-PAGE pre-fractionation of proteins (26 fractions) | LTQ-Orbitrap Velos Pro | One peptide with an FDR of <5% | 1873 |
| Dor et al., Exp. Eye Res., 2019 [ | Characterization of healthy human tear protein composition | Schirmer strips | Off-gel electrophoresis of peptides (12 fractions) | LTQ-Orbitrap Velos Pro | Two peptides with FDRs of <1% | 1351 |
| Nättinen et al., Trans. Vis. Sci. Tech., 2020 [ | Investigation of protein profile differences between capillary and Schirmer strip tear fluid samples | Schirmer strips | No pre-fractionation (in-solution digestion of whole samples) | TripleTOF 5600 + in SWATH-MS mode | FDR <1% | 908 |
| Capillary method | 404 | |||||
| Hua et al., BMC Ophthalmol., 2020 [ | Quantification of potential candidate biomarkers for HSV-1 epithelial keratitis | Microcapillary method | No pre-fractionation (in-solution digestion of whole samples) | LTQ-Orbitrap XL | FDR <1% | 949 |
| Ponzini et al., Int. J. Mol. Sci., 2021 [ | Demonstration of feasibility of single-tear quantitative proteomics | Capillary method | No pre-fractionation (in-solution digestion of whole samples) | Orbitrap fusion | One peptide with an FDR of <1.0% | 932 |
| Zysset-Burri et al., Inv. Ophthalmol. Vis. Sci., 2021 [ | Exploring the interplay between the ocular surface microbiome and the tear proteome | Schirmer strips | With pre-fractionation of (5 factions) proteins with one-dimensional SDS-PAGE | QExactive HF | FDR <1% | 2172 |
Figure 1Number of identified proteins (NIPs) and their distributions in the various sections of the Schirmer strips (ScS). (a) Effect of processing two different sections of the ScS (B + R) on the NIPs. (b) Comparison of the NIPs between the two sections of the ScS and section R. (c) Venn diagram displaying the comparison of the NIPs in the whole strip (W), bulb (B), and the rest of the strip (R).
List of identified proteins previously described in ocular surface disease. The mean spectral count and standard deviation (SD) of each protein in the whole strip (W), the bulb (B), and the rest (R) of the strip are presented. The proteins are classified as those common in all batches (1), two batches (2), or one batch (3) and are ranked according to their mean of spectra in W. *, proteins reported in dry eye disease studies. Accession number refers to UniProt identification.
| Accession Number | Protein Name | W | B | R |
|---|---|---|---|---|
| Mean ± SD | ||||
| (1) Common in all batches | ||||
| P12273 | Prolactin-induced protein [ | 142.3 ± 14 | 108 ± 15.4 | 121.7 ± 2.5 |
| P98160 | Heparan sulfate proteoglycan 2 [ | 113.3 ± 5.5 | 56.3 ± 4.9 | 123.7 ± 1.5 |
| P61626 | Lysozyme C * [ | 111.3 ± 6.7 | 104 ± 4.6 | 108.7 ± 5.5 |
| P01876 | Ig alpha-1 chain C region [ | 107 ± 2.6 | 61.7 ± 3.2 | 74 ± 4.4 |
| P02768 | Serum albumin * [ | 101.7 ± 2.1 | 204.3 ± 8.1 | 67 ± 4 |
| P02788 | Lactotransferrin * [ | 100.7 ± 5.6 | 130.3 ± 7.1 | 101.7 ± 3.5 |
| P01024 | Complement C3 [ | 72.7 ± 3.2 | 69.7 ± 1.5 | 62.7 ± 2.1 |
| Q9UGM3 | Salivary agglutinin [ | 50.7 ± 4 | 48 ± 2 | 54.3 ± 0.6 |
| P31025 | Lipocalin-1 * [ | 45.3 ± 2.1 | 50 ± 3.6 | 36.7 ± 2.3 |
| P00352 | Retinal dehydrogenase 1 [ | 35.3 ± 2.1 | 46 ± 4 | 24.7 ± 2.1 |
| O75556 | Mammaglobin-B [ | 35.3 ± 0.6 | 18 ± 1 | 6.3 ± 1.2 |
| P06733 | Alpha-enolase [ | 31.3 ± 1.2 | 52 ± 4.6 | 27.3 ± 0.6 |
| P02787 | Serotransferrin [ | 24.7 ± 3.1 | 59 ± 4 | 26.7 ± 1.5 |
| P07900 | Heat shock protein HSP 90-alpha [ | 22.3 ± 1.5 | 8 ± 2.6 | 24.3 ± 1.5 |
| P04083 | Annexin A1 [ | 22.3 ± 0.6 | 24.7 ± 0.6 | 18 ± 1 |
| P06702 | Protein S100-A9 [ | 19 ± 1 | 28.7 ± 2.1 | 22 ± 1 |
| P07858 | Cathepsin B [ | 18.3 ± 1.5 | 19.7 ± 1.5 | 22 ± 1.7 |
| P47895 | Aldehyde dehydrogenase family 1 member A3 [ | 18 ± 2.6 | 23.7 ± 1.5 | 6.3 ± 2.1 |
| P00738 | Haptoglobin [ | 18 ± 2 | 19 ± 1.7 | 14 ± 0 |
| P30740 | Serpin B1 [ | 15.7 ± 2.1 | 24.3 ± 1.2 | 8.7 ± 3.2 |
| P05109 | Protein S100-A8 [ | 15.7 ± 0.6 | 22.3 ± 3.2 | 22 ± 2.6 |
| P25311 | Zinc-alpha-2-glycoprotein [ | 12.7 ± 1.5 | 14.3 ± 1.5 | 16.3 ± 1.5 |
| P07355 | Annexin A2 [ | 12.7 ± 1.2 | 36.7 ± 3.5 | 25 ± 1 |
| P18510 | Interleukin 1 receptor antagonist protein [ | 9.7 ± 1.5 | 12.3 ± 1.5 | 7 ± 1 |
| Q8WUM4 | Programmed cell death 6-interacting protein [ | 9 ± 0 | 2.7 ± 0.6 | 5 ± 1.7 |
| P23528 | Cofilin-1 [ | 8.7 ± 3.8 | 15.3 ± 2.1 | 8.7 ± 2.1 |
| P07476 | Involucrin [ | 6 ± 1 | 3 ± 1.7 | 20.3 ± 2.3 |
| P01023 | Alpha-2-macroglobulin [ | 5.3 ± 1.5 | 15.7 ± 2.3 | 7.7 ± 1.2 |
| Q6UXB2 | C-X-C motif chemokine ligand 17 [ | 1 ± 1 | 0.7 ± 1.2 | 1 ± 1 |
| (2) Common to two batches | ||||
| P98088 | Mucin-5AC [ | 10.3 ± 0.6 | 54.3 ± 3.8 | 0 |
| Q14116 | Interleukin 18 [ | 0.7 ± 0.6 | 2 ± 1 | 0 |
| P02778 | C-X-C motif chemokine ligand 10 [ | 2 ± 0 | 0 | 0.3 ± 0.6 |
| (3) Unique to one batch | ||||
| Q9UHD0 | Interleukin 19 [ | 0.7 ± 1.2 | 0 | 0 |
| P14780 | Matrix metallopeptidase 9 * [ | 0 | 0.3 ± 0.6 | 0 |
| P29508 | Serpin B3 [ | 0 | 0 | 23.7 ± 2.5 |
| P48594 | Serpin B4 [ | 0 | 0 | 12 ± 1 |
| Q9UHA7 | Interleukin 36 alpha [ | 0 | 0 | 0.3 ± 0.6 |
Figure 2Functional analysis and structural classification of identified proteins. (a) Subgroups of the biological process. (b) Subgroups of molecular function. The NIPs illustrated in the x-axis show the numbers of proteins involved in (a,b). (c) The list and number of protein classes in each ScS section and all batches. (d) Distribution and classification of all identified enzymes.
Figure 3Barcodes of the major signaling pathways and NIPs in each ScS batch. The six signaling pathways were distributed as apoptosis, complement, interferons (IFNs) signaling, matrix metalloproteinases (MMPs), cell junction, and lipid metabolism in the whole strip (W), the bulb (B), and the rest (R). Each bar represents one protein. The total NIPs (W + B + R) are indicated between the bracket above each pathway barcode, and the corresponding NIPs for each batch are indicated between brackets on the left.
Figure 4Illustrations of tear sample collection with ScS and sample processing. Eight ScS were collected from two HSs without anesthesia in 4 different sampling periods over 2 days. Two equivalent groups of the ScS were obtained by pooling them. In the first group, whole strips (W) were used; in the second group, the strips were cut to separate the bulbs (B) and the rest of the strips (R). The 4 pooled W strips (a), 4 B strips (b), and 4 R strips (c) were extracted in ammonium bicarbonate to prepare an analytical sample for protein quantification and MS analysis. R, right eye; L, left eye; a.m., in the morning; p.m., in the afternoon; 1, healthy subject-1; 2, healthy subject-2; ScS, Schirmer strips; W, the whole strip; B, the bulb; R, the rest of the strip.
Figure 5Heat-map visualization of ion mobility. The peptide ions of two different proteins with almost the same mass-to-charge ratio (m/z) at a single time point were differentiated by the timsTOF Pro analysis. The circled lines indicate the m/z and mobility positions of two precursor ions selected for fragmentation by parallel accumulation-serial fragmentation (PASEF). *; (1/k0), the drift time.